丙酸倍氯松吸入对儿童支原体感染诱发咳嗽变异性哮喘预后的影响  

Effect of taking beclomethason dispropionate (BDP) at prognosis of cough variant asthma(CVA) caused by infection of mycoplasma pneumoniae

作　　者：岑赛宁[1] 张国华[1] 蔡卫华[1] 

机构地区：[1]广东省佛山市妇幼保健院,528000

出　　处：《中国妇幼保健》2005年第3期277-278,共2页Maternal and Child Health Care of China

摘　　要：目的 :探讨不同疗程丙酸倍氯松 (BDP)吸入对支原体感染诱发咳嗽变异性哮喘 (CVA)预后的影响。方法 :将 60例血清肺炎支原体IgM抗体呈阳性反应的CVA患儿随机分成长疗程组和短疗程组 ,分别吸入BDP 12～ 2 4周或 2周。结果 :CVA复发率、血清总IgE持续升高率、发展成支气管哮喘率 ,在两组间有显著性差异。结论 :CVA患儿按哮喘病治疗 ,在缓解期后继续给予吸入皮质激素 ,有利于CVA的预后。Objective:To explore the effect of taking beclomethason dispropionate(BDP) in different period of treatment on prognosis of cough variant asthma(CVA) caused by infection of mycoplasma pneumoniae.Methods:Separating 60 CVA infants whose blood serum mycoplasma pneumoniae IgM antibody is positve randomly into two groups:long period of treatment group in which each takes BDP for 12 to 24 weeks,and short period of treatment group in which each takes BDP for 2 weeks.Results:There is a significant difference between the two groups in the rates of CVA recrudescence,blood serum total IgE continuous raising,and developing into bronchia asthma.Conclusion:It is good for CVA prognosis or for infants suffering from CVA treated as ones suffering from asthma to continue to take BDP after the serious time.

关 键 词：哮喘 丙酸倍氯松 疗程 预后 

分 类 号：R725.6[医药卫生—儿科]